Celebrating Skylar's 21st Birthday with 21 Miles - 20 Miles Down, 1 Mile to Go
Celebrating Skylar's 21st Birthday with 21 Miles - 20 Miles Down, 1 Mile to Go
TIME EQUALS NEURONS for infants diagnosed with SMA. Early diagnosis leads to earlier treatment, preserving neurons and function.
Cure SMA is beginning to focus on combination therapies that stop progression and increase muscle strength and function.
Genentech receives FDA approval of Evrysdi, an oral medication, for spinal muscular atrophy for adult patients and children two+ months.
AveXis receives FDA approval of Zolgensma, a gene therapy, for spinal muscular atrophy for patients under two years of age.
Biogen receives FDA approval of Spinraza, making it the first-ever treatment for all patients with spinal muscular atrophy.
Copyright © 2022 Reach4Sky.com - All Rights Reserved.
Powered by GoDaddy